Chi Sheng Pharma & Biotech Co., Ltd
TWO: 4111.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Dongmao Su
- Headquarters
- Hsinchu, Taiwan
- IPO year
- 2007
- Market cap
- NT$1.8B
- Website
- https://www.cscp.com.tw
Loading 4111…
Loading profile data…Frequently asked questions about 4111
What does Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) do?
Chi Sheng Pharma & Biotech Co., Ltd engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally. Its products portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations...
Where does 4111.TWO trade?
Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) trades on the Taipei Exchange.
What sector is 4111.TWO in?
Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Chi Sheng Pharma & Biotech Co., Ltd?
Dongmao Su is the chief executive officer of Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO).
Where is Chi Sheng Pharma & Biotech Co., Ltd headquartered?
Chi Sheng Pharma & Biotech Co., Ltd is headquartered in Taiwan.
Does 4111.TWO pay a dividend?
Yes — Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) paid a trailing twelve-month dividend of TWD 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4111.TWO go public?
Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) completed its initial public offering in 2007.